Wounds destroy healthy skin and mucous membranes that appear in multiple ways such as brass, laceration, puncture and avulsion. Wounds can be permanent or acute. Acute wounds are caused by injuries and are sustained by surgery. In comparison, chronic injuries are associated with significant systemic diseases such as pneumonia, dental ulceration, stomatitis and slow wound healing and usually do not heal adequately and rapidly.
Access Full Report at https://www.databridgemarketresearch.com/reports/global-advanced-wound-care-market
Data Bridge Market Research analyses that the Advanced Wound Care Market was valued at USD 9.4 billion in 2021 and is expected to reach USD 15.91 billion by 2029, registering a CAGR of 6.80% during the forecast period of 2022 to 2029. The demand for advanced wound care will increase further due to the sharp increase in hospital visits for wound treatment. Growing healthcare spending to provide better patient care and a significant number of therapeutic operations carried out in hospitals will boost the expansion of the hospital industry. Furthermore, the prevalence of pressure ulcers developed in hospitals is rising, increasing the need for better wound care and raising the industry's worth.
The increasing prevalence of chronic diseases and conditions that affect the wound healing capacities across the world will drive the market's growth rate
Over the past ten years, there has been an increase in the prevalence of acute, chronic, and surgical wounds due to factors including an expanding global elderly population, rising traumatic wounds, an increase in surgeries, and an increase in the incidence of diseases including obesity and diabetes. Diabetes and obesity can significantly increase the frequency and complexity of wounds, including infections, ulcerations (such as leg or foot ulcers), and chronic wounds. These wounds all require therapy (advanced wound management), which raises the expense of healthcare.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Dressing, Therapy Device, Biologics, Others), Wound Type (Primary Wound Care, Secondary Wound Care), Wound Class (Class I, Class II, Class III, Class IV), End User (Hospitals, Wound Care Centres, Ambulatory Centres, Home Healthcare, Clinics, Others), Distribution Channel (Direct Tenders, Retail)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
3M (U.S.), Smith+Nephew (U.K.), ConvaTec Group Plc (U.K.), Coloplast Group (Denmark), Mölnlycke Health Care AB (Sweden), Integra LifeSciences (U.S.), PAUL HARTMANN (Germany), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Organogenesis Inc. (U.S.), Misonix, Inc. (U.S.), MIMEDX (U.S.), Zimmer Biomet (U.S.), Lohmann & Rauscher GmbH & Co. KG (Germany), DeRoyal Industries, Inc. (U.S.), Medline Industries, Inc. (U.S.), Johnson & Johnson Private Limited (U.S.), Baxter (U.S.), Medtronic (Ireland), Hollister Incorporated (U.S.) among others
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
Global advanced wound care market is segmented into five notable segments which are on the basis of the product type, wound type, wound class, end user and distribution channel.
- On the basis of product type, the advanced wound care market is classified into dressing, biologics, therapy devices and others. In 2021, dressing segment is expected to dominate the advanced wound care market with 44.6% market share because it is considered to be the first step in wound treatment as well as plays an important role in wound management.
- On the basis of wound type, the global advanced wound care market is classified into primary wound care and secondary wound care. In 2021, primary wound care segment is expected to dominate the market with 69.6% market share because it is considered to be the first step in wound treatment as well as plays an important role in wound management. After primary wound care, secondary wound care type is done to cover the wound.
- On the basis of end user, the global advanced wound care market is classified into hospitals, wound care centers, ambulatory centers, home healthcare, clinics and others. In 2021, hospitals segment is expected to dominate the market with 44.1% market share as higher number of patients prefer to visit hospitals for different cases such as surgical wound, burns, ulcers and others. However, wound care centers segment is growing with the highest growth rate because of the availability of better facility and treatment of patients for wounds.
The hospitals segment will dominate the end user segment of the advanced wound care market
The hospitals segment will emerge as the dominating segment end user segment. This is because of the growing number of clinics in the market especially in the developing economies. Further, growth and expansion of research development services on a global scale will further bolster the growth of this segment.
- On the basis of distribution channel, the global advanced wound care market is classified into direct tenders and retail. In 2021, direct tenders segment is expected to dominate the market with 78.8% market share as majority of the products related to advanced wound care is directly distributed to various places such as hospitals, wound care center and others.
The direct tender segment will dominate the distribution channel segment of the advanced wound care market
The direct tender segment will emerge as the dominating segment under distribution channel. This is because of the growing number of infrastructural development activities in the market especially in the developing economies. Further, growth and expansion of the healthcare industry all around the globe will further bolster the growth of this segment.
Major Players
Data Bridge Market Research recognizes the following companies as the market players in market: 3M (U.S.), Smith+Nephew (U.K.), ConvaTec Group Plc (U.K.), Coloplast Group (Denmark), Mölnlycke Health Care AB (Sweden), Integra LifeSciences (U.S.), PAUL HARTMANN (Germany), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Organogenesis Inc. (U.S.), Misonix, Inc. (U.S.), MIMEDX (U.S.), Zimmer Biomet (U.S.), Lohmann & Rauscher GmbH & Co. KG (Germany), DeRoyal Industries, Inc. (U.S.), Medline Industries, Inc. (U.S.), Johnson & Johnson Private Limited (U.S.), Baxter (U.S.), Medtronic (Ireland), Hollister Incorporated (U.S.).
Market Development
- In 2019, AxioBiosolutions launched MaxioCel during Endovascular Live 2019 in New Delhi, a next-generation Chitosan-based wound dressing with pain management and scar improvement properties. This product can be used for the treatment of various types of chronic wounds such as diabetic foot ulcers, venous ulcers, cavity wounds, skin abrasions, donor sites and post-operative surgical wounds and various other types of complex chronic wounds. This will help to heal the wound in lesser time.
- In June 2019, Smith+Nephew launched the PICO 14 Single Use Negative Pressure Wound Therapy System (sNPWT) having pump duration for 2 weeks which can be used for deep wounds of 7 centimeters deepness without any user intervention. This reduces the requirement for fillers and decreases frequency of dressing as compared with traditional system. This product uses AIRLOC technology which offers even and reliable delivery of therapeutic NPWT in the wound and the surrounding area of injury.
- In May 2018, Coloplast Group launched Biatain Silicone with 3DFit technology. Biatain Silicone provides a comprehensive range of foam dressings to offer flexibility in curing injuries or preventing pressure injuries. This product is available in wide range of sizes.
Regional Analysis
Geographically, the countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in advanced wound care market during the forecast period 2022 to 2029
North America dominates the advanced wound care market because of the growing adoption of advanced technology and launch of new products in this region. Additionally, increasing number of cases of chronic wounds and rising geriatric population will further enhance the market's growth rate in this region.
Asia-Pacific is estimated to be the fastest-growing region in advanced wound care market the forecast period 2022 to 2029
Asia-Pacific is expected to grow during the forecast period due to presence of major market players in this region. In addition, rising level of healthcare expenditure will propel the market's growth rate in this region.
COVID-19 Impact
The World Health Organization (WHO) has declared the COVID-19 virus a public health emergency because of its global spread since its discovery in December 2019. Since many nations adopted lockdown to stop COVID-19 from spreading within communities, the virus's negative effects on the industry have been noted. The market faced a short-term disruption that had a negative effect because of supply chain disruptions and a decline in non-urgent in-person clinic appointments. Due to the coronavirus's quick spread, some manufacturers were forced to stop their production and manufacturing activities. The potential for people to become infected with COVID-19 in hospitals and other healthcare facilities restrained market growth.
For more detailed information about the advanced wound care market, visit: https://www.databridgemarketresearch.com/reports/global-advanced-wound-care-market
